The GoodRx Prescription Savings Blog

The latest updates on prescription drugs and ways to save from the GoodRx medical team

FDA Approval Revoked for Several Popular Cholesterol Drugs

by Dr. Sharon Orrange on April 19, 2016 at 2:59 pm

This week, the FDA took the unusual step of withdrawing approvals it had previously given for several medications used in conjunction with statins to treat high cholesterol. This is news because I’m sure many of you have been paying big bucks for these medications.

Which meds are we talking about?

Why did the FDA pull approval of these meds?

Because they haven’t been shown to have any benefit. Simply put, when added to statin therapy (atorvastatin/Lipitor, simvastatin/Zocor, Crestor) for lowering triglycerides or raising HDL cholesterol, they haven’t been shown to reduce risk of heart disease or stroke. So, they don’t really help you.

Based on several large trials, the FDA decided that “scientific evidence no longer supports the conclusion that a drug-induced reduction in triglyceride levels and/or increase in HDL-cholesterol levels in statin-treated patients results in a reduction in the risk of cardiovascular events.”

The benefits of niacin extended release tablets and fenofibric acid capsules listed above, for use alone or with your statin medications, no longer outweigh the risks.

Thoughts?

Dr O.


Copyright ©2015 GoodRx, Inc.

This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment. Third party logos, trademarks, brand names and images contained on GoodRx.com are for demonstration purposes only and are owned by their respective rights holders, who are not affiliated with this Site.